Historic EPS (Weighted Average and Diluted) for Nuvation Bio (NUVB) over the last 3 years, with Jun 2025 value amounting to -$0.17.
- Nuvation Bio's EPS (Weighted Average and Diluted) rose 91.01% to -$0.17 in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.37, marking a year-over-year decrease of 11.79%. This contributed to the annual value of -$2.11 for FY2024, which is 502.86% down from last year.
- Per Nuvation Bio's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.17 for Q2 2025, which was down 6.25% from -$0.16 recorded in Q1 2025.
- Nuvation Bio's 5-year EPS (Weighted Average and Diluted) high stood at -$0.07 for Q4 2023, and its period low was -$106.13 during Q3 2021.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.10 (2023), whereas its average is -$0.31.
- As far as peak fluctuations go, Nuvation Bio's EPS (Weighted Average and Diluted) spiked by 99.89% in 2022, and later crashed by 2,000.00% in 2024.
- Nuvation Bio's EPS (Weighted Average and Diluted) (Quarterly) stood at -$106.13 in 2021, then surged by 99.89% to -$0.09 in 2022, then increased by 22.22% to -$0.07 in 2023, then crashed by 66.67% to -$0.15 in 2024, then skyrocketed by 91.01% to -$0.17 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.17 for Q2 2025, versus -$0.16 for Q1 2025 and -$0.15 for Q3 2024.
